News
The symptoms of this inflammatory disease can seem disconnected, which is why it’s important to know what to look for.
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...
The LookFantastic Hair Volume Edit, £45, is a seven-piece bundle that aims to boost flat hair and amplify locks effortlessly.
3d
MedPage Today on MSNThis Drug May Safely Treat Psoriasis Exacerbations From Cancer TherapyOne of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened ...
A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...
Discover a study showing low and stable cancer risk in patients with PsO, PsA, and axSpA treated long-term with ixekizumab.
From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.
On behalf of our sponsors at Arcutis Biotherapeutics, we're learning more about Plaque Psoriasis, the chronic, inflammatory skin disease that affects many people and a new topical treatment that may ...
“Wrinkles on the neck can be improved with various treatments, including topical creams, in-office procedures such as laser ...
WSFL Miami-Fort Lauderdale, FL on MSN4d
New Treatment Offers Hope for People Living with Plaque PsoriasisThere’s a new ‘bonus’ tax deduction worth $6,000 for older taxpayers — here’s who qualifies ...
Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...
3d
Pharmaceutical Technology on MSNLEO Pharma secures rights to Boehringer’s Spevigo for $105mLEO has plans for Spevigo beyond generalised pustular psoriasis as it looks to boost its dermatological pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results